ROCK
Rho-kinase (EC 2.7.11.1) is a serine/threonine kinase belonging to the AGC-family of protein kinases, originally identified as the first downstream effector of the small GTPase Rho. There are two Rho-kinase members, Rho-kinase α/ROCK2/ROKα and Rho-kinase β/ROCK1/ROKβ; both Rho-kinases are composed of an N-terminal catalytic domain, a central coiled-coil domain, and a C-terminal PH domain interrupted by a Cys-rich region. Rho-family small GTPases, such as Rho, Rac, and Cdc42, mediate a broad range of cellular responses that involve the actin cytoskeleton. Rhoregulates stress fiber formation and cell contraction, whereas Rac and Cdc42 regulate the formation of lamellipodia and filopodia, respectively, and promote protrusive activities. Rho-family GTPases also modulate microtubule dynamics and cell polarity. Furthermore, Rho-kinase is involved in smooth muscle contraction and actin organization, cell migration, neuronal architecture and neurite elongation, and cytokenesis, among several other functions[1],[2].
[1] Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. M. Amano, M. Nakayama, K. Kaibuchi. Cytoskeleton 2013, 67, 545-554.
[2]Rho Kinase (ROCK) Inhibitors. J.K. Liao, M. Seto, K. Noma. J. Cardiovasc. Pharmacol. 2007, 50, 17-24.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
2187 | AS 1892802 | Potent, selective, ATP-competitive ROCK inhibitor | €95.00 | |
2166 | AT 13148 dihydrochloride | ATP-competitive inhibitor of multi-AGC kinases | €70.00 | |
3848 | Fasudil hydrochloride | Orally active ROCK inhibitor; Ca2+ channel antagonist | €50.00 | |
1167 | GSK 269962A | ROCK1 and ROCK2 inhibitor | €65.00 | |
2780 | KD025 | Selective ATP-competitive inhibitor of ROCK2 | €95.00 | |
5011 | Naive Stem Cell 5i inhibitor Set | Set of five inhibitors for the induction and maintenance of human naive stem cell pluripotency | €200.00 | |
5010 | Naive Stem Cell NHSM inhibitor Set | Set of inhibitors for isolation, generation, derivatization and stabilization of naive hPSCs | €230.00 | |
2229 | RKI 1447 | Potent inhibitor of the Rho-associated ROCK kinases | €105.00 | |
5009 | Stem Cell 4i inhibitor Set | Set of Thiazovivin, SB 431542, PD0325901, and CHIR99021 (inhibitors of ROCK, TGF-β, MEK, and GSK-3 resp.) | €170.00 | |
1535 | Thiazovivin | ROCK inhibitor and iPSC stimulator; Stem cell related | €90.00 | |
1683 | Y 27632 dihydrochloride | ROCK1 and ROCK2 inhibitor | €65.00 |